Hertraz 440mg Injection

Product Description

1. Product Overview:

Hertraz 440 mg Injection is a high-quality oncology medication containing Trastuzumab 440 mg, a monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. It is a targeted therapy that works by binding to the HER2 receptor and inhibiting the growth of cancer cells.

Manufactured by Mylan (Biocon Biologics), Hertraz is a trusted biosimilar of Herceptin.

2.Key Product Information:

• Brand Name: Hertraz

• Strength: 440 mg per vial (with sterile water for injection)

• Form: Lyophilized powder for intravenous infusion

• Packaging: Single-use vial with diluent

• Therapeutic Category: Oncology / Antineoplastic

• Administration: Intravenous infusion under medical supervision

• Prescription Required: Yes

• Storage: 2C to 8C (refrigerated), do not freeze

3. Indications:

• HER2-positive early breast cancer

• Metastatic breast cancer

• HER2-overexpressing metastatic gastric cancer

• Highly effective targeted therapy with proven clinical outcomes

• WHO and FDA-approved molecule

• Biosimilar to Roches Herceptin at a more affordable price point

• Suitable for use in combination with chemotherapy agents (e.g., Paclitaxel, Docetaxel)

Trusted Oncology Solution

Hertraz 440mg Injection stands out as a reliable treatment option for patients diagnosed with HER2-positive cancers. It is formulated to meet rigorous standards and distributed by exporters and wholesalers across India. The product ensures maximum potency and safety when stored as recommended, helping patients and medical practitioners in the fight against cancer.


Proper Storage for Maximum Potency

To ensure the effectiveness of Hertraz 440mg Injection, always store the product in a cool, dry environment. Incorrect storage conditions may compromise its stability and reduce the intended 12-month shelf life. Adhering to these storage instructions supports the medications efficacy and guarantees optimal results in cancer therapy.